In the US, the incidence rate of testicular cancer has been increasing for several decades without evidence pointing to any particular lead as to why. Still, testicular cancer is not common: about 1 in every 263 males will develop it. It can also usually be treated successfully, and a man’s risk of dying from the disease is very low.

This doesn’t mean that one shouldn’t acquaint themselves with the possible risk factors and signs and symptoms of testicular cancer. Help spread the word!

Copyright © 2018 CancerConnect. All Rights Reserved.

Recommended Articles

Image placeholder title

Tisotumab Vedotin – Promising in Advanced Cervical Cancer

Novel precision cancer medicine promising for treatment of advanced ovarian cancer.

Image placeholder title

Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer

Checkpoint inhibitor immunotherapy prolongs survival and delays recurrence in advanced cervical cancer.

Ovarian News Updates

Precision Antibody-drug conjugate promising in Ovarian Cancer

Learn about the STRO-002 Antibody-drug conjugate in Ovarian Cancer